Trial Outcomes & Findings for Thromboelastography-derived Functional Fibrinogen Levels (NCT NCT01992757)

NCT ID: NCT01992757

Last Updated: 2018-10-03

Results Overview

FLEV values obtained during rewarming while on cardiopulmonary bypass (CPB) were compared to FLEV values obtained immediately after CPB and protamine administration. For all patients included, the mean values for rewarming FLEV and mean values for post-CPB FLEV were obtained. If the mean difference for the two timepoints was not statistically different by t-test, then the primary outcome would demonstrate the value of obtaining a rewarming FLEV sample.

Recruitment status

COMPLETED

Target enrollment

51 participants

Primary outcome timeframe

Change in FLEV from rewarming and after cardiopulmonary bypass

Results posted on

2018-10-03

Participant Flow

Participant milestones

Participant milestones
Measure
Cardiac Surgery With Cardiopulmary Bypass
Patients over the age of 18 years undergoing cardiac surgery requiring CPB. Patients were excluded based on their need for emergency surgery, re-operative cardiac surgery, a history of coagulation disorders, and inability to sign consent.
Overall Study
STARTED
51
Overall Study
COMPLETED
49
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Cardiac Surgery With Cardiopulmary Bypass
Patients over the age of 18 years undergoing cardiac surgery requiring CPB. Patients were excluded based on their need for emergency surgery, re-operative cardiac surgery, a history of coagulation disorders, and inability to sign consent.
Overall Study
2 patients excluded due to FFP given.
2

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cardiac Surgery With Cardiopulmary Bypass
n=49 Participants
patients over the age of 18 years undergoing cardiac surgery requiring CPB. patients were excluded based on their need for emergency surgery, re-operative cardiac surgery, a history of coagulation disorders, and inability to sign consent.
Age, Categorical
<=18 years
0 Participants
n=49 Participants
Age, Categorical
Between 18 and 65 years
26 Participants
n=49 Participants
Age, Categorical
>=65 years
23 Participants
n=49 Participants
Age, Continuous
63.1 years
n=49 Participants
Sex: Female, Male
Female
20 Participants
n=49 Participants
Sex: Female, Male
Male
29 Participants
n=49 Participants
Region of Enrollment
United States
49 participants
n=49 Participants

PRIMARY outcome

Timeframe: Change in FLEV from rewarming and after cardiopulmonary bypass

Population: 49 patients undergoing cardiac surgery with CPB.

FLEV values obtained during rewarming while on cardiopulmonary bypass (CPB) were compared to FLEV values obtained immediately after CPB and protamine administration. For all patients included, the mean values for rewarming FLEV and mean values for post-CPB FLEV were obtained. If the mean difference for the two timepoints was not statistically different by t-test, then the primary outcome would demonstrate the value of obtaining a rewarming FLEV sample.

Outcome measures

Outcome measures
Measure
FLEV Difference During Rewarming & Post-cardiopulmonary Bypass
n=49 Participants
All enrolled patients were in a single arm with multiple timepoints. FLEV values were obtained at baseline, rewarming, and post-CPB. The primary outcome was to compare the rewarming and post-CPB values to determine if a significant difference exists.
Change in Thromboelastography-derived Functional Fibrinogen Level (FLEV)
-1.1 mg/dL
Interval -25.8 to 23.6

SECONDARY outcome

Timeframe: Clauss vs FLEV for rewarming and post-CPB

Population: 49 patients undergoing cardiac surgery with CPB. The measure is the difference of the FLEV and the Clauss assay (i.e. FLEV minus Clauss since the FLEV is consistently higher).

This secondary outcome aimed to determine if standard laboratory assays for fibrinogen (Clauss) provided values similar to TEG-based functional fibrinogen (FLEV). The difference between the means at various timepoints is calculated in mg/dL.

Outcome measures

Outcome measures
Measure
FLEV Difference During Rewarming & Post-cardiopulmonary Bypass
n=49 Participants
All enrolled patients were in a single arm with multiple timepoints. FLEV values were obtained at baseline, rewarming, and post-CPB. The primary outcome was to compare the rewarming and post-CPB values to determine if a significant difference exists.
Difference in Clauss Assay and FLEV
Mean Clauss vs FLEV difference at rewarming
120.6 mg/dL
Interval 104.1 to 137.1
Difference in Clauss Assay and FLEV
Mean Clauss vs FLEV difference post-CPB
119.5 mg/dL
Interval 101.7 to 137.4

Adverse Events

Cardiac Surgery With Cardiopulmary Bypass

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Rupa Chowdary

University of Pennsylvania Hospital

Phone: 215-615-4105

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place